---
title: "Akanda Corp. (AKAN.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AKAN.US.md"
symbol: "AKAN.US"
name: "Akanda Corp."
industry: "Pharmaceuticals"
datetime: "2026-05-19T14:09:28.608Z"
locales:
  - [en](https://longbridge.com/en/quote/AKAN.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AKAN.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AKAN.US.md)
---

# Akanda Corp. (AKAN.US)

## Company Overview

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.akandacorp.com](https://www.akandacorp.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:13.000Z

**Overall: C (0.55)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 101 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 183.67% |  |
| Net Profit YoY | 92.34% |  |
| P/B Ratio | 2.64 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 8711013.40 |  |
| Revenue | 836664.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -60.86% | E |
| Profit Margin | -266.31% | E |
| Gross Margin | 0.00% | E |
| Revenue YoY | 183.67% | A |
| Net Profit YoY | 92.34% | A |
| Total Assets YoY | -37.63% | E |
| Net Assets YoY | -27.77% | E |
| Cash Flow Margin | 79.17% | C |
| OCF YoY | 183.67% | A |
| Turnover | 0.10 | E |
| Gearing Ratio | 46.88% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Akanda Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "183.67%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "92.34%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "8711013.40",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "836664.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-60.86%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-266.31%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "0.00%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "183.67%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "92.34%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-37.63%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-27.77%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "79.17%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "183.67%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.10",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "46.88%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.91 | 151/190 | - | - | - |
| PB | 2.64 | 103/190 | 0.73 | 0.60 | 0.37 |
| PS (TTM) | 10.41 | 117/190 | 3.65 | 2.86 | 1.46 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AKAN.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AKAN.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AKAN.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AKAN.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**